0000899243-18-028888.txt : 20181114 0000899243-18-028888.hdr.sgml : 20181114 20181114145233 ACCESSION NUMBER: 0000899243-18-028888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181107 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buell Jennifer CENTRAL INDEX KEY: 0001711184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 181182908 BUSINESS ADDRESS: BUSINESS PHONE: 781-674-4400 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-07 0 0001098972 AGENUS INC AGEN 0001711184 Buell Jennifer C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 Chief Operating Officer Stock Option (right to buy) 2.07 2018-11-07 4 A 0 130000 0.00 A 2027-11-07 Common Stock 130000 130000 D Represents the grant of an option to purchase shares of common stock. The stock option was awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Investment Plan, and vests over three years with one-third of the award vesting on November 7, 2019 and the balance vesting in equal quarterly installments thereafter. /s/ Evan D. Kearns, by Power of Attorney 2018-11-14 EX-24 2 attachment1.htm EX-24 DOCUMENT
                               POWER OF ATTORNEY
        For Obtaining EDGAR Access Codes and Executing Forms 3, 4 and 5

    Know all by these presents, that the undersigned hereby constitutes and
appoints each of Garo H. Armen, Christine M. Klaskin, Karen H. Valentine and
Evan D. Kearns, signing singly, his/her true and lawful attorney-in-fact to:

    (1)	execute for and on behalf of the undersigned all forms necessary to
        revive or obtain new EDGAR Access Codes for the undersigned, including
        without limitation, PMAC, CCC and passwords necessary to enable the
        undersigned to make filings in the United States Securities and Exchange
        Commission's EDGAR system;

    (2)	execute for and on behalf of the undersigned Forms 3, 4 and 5 in
        accordance with Section 16(a) of the Securities Exchange Act of 1934 and
        the rules thereunder, and any other forms or reports the undersigned may
        be required to file, in connection with the undersigned's ownership,
        acquisition, or disposition of securities of Agenus Inc., a Delaware
        corporation;

    (3)	do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete the execution of any
        such Form 3, 4 and 5, or other form or report, complete and execute any
        amendment or amendments thereto, and the timely filing of such form with
        the United States Securities and Exchange Commission and any other
        authority; and

    (4)	take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in his/her discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as such attorney-in-fact
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
his/her substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys- in-fact, in serving in
such capacity at the request of the undersigned, are not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by Agenus Inc.,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 5th day of July, 2017.


/s/Jennifer Buell
-------------------------------
Jennifer Buell